Jeremy Pettus explains the pros and cons of SGLT2s for people with type 1, and offers advice on how to try them safely and smartly.
read more →
SGLT2s are currently only approved for use in the U.S. for type 2 diabetes, but a lot of people with type 1 are taking them off label with positive results.
read more →
Just a few minutes of meditation each day can have a big impact on stress reduction, which is so important for people living with the challenges of diabetes.
read more →
Driven by his jealousy over Jeremy’s amazing time-in-range with DIY Looping, Steve gives it a go with his Omnipod and is blown away by the results.
read more →
Exciting new advances in glucagon delivery are right around the corner – injector pens, nasal sprays and mini-doses that can be self-administered.
read more →
